CureVac N.V. (NASDAQ:CVAC) Q3 2024 Earnings Conference Call November 12, 2024 9:00 AM ET
Company Participants
Sarah Fakih – Vice President of Corporate Communications and Investor Relations
Alexander Zehnder – Chief Executive Officer
Axel Malkomes – Chief Financial Officer
Myriam Mendila – Chief Development Officer
Rudiger Wolff – Senior Vice President of Finance
Conference Call Participants
Charlie Yang – Bank of America Merrill Lynch
CJ Yeh – Leerink Partners
Roy Buchanan – Citizens JMP
Operator
Greetings and welcome to the CureVac Financial Results and Business Update for the Third Quarter and First Nine Months of 2024 Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Sarah Fakih, Vice President of Corporate Communications and Investor Relations. Thank you. You may begin.
Sarah Fakih
Thank you. Good morning, good afternoon, and welcome to our conference call. My name is Sarah Fakih, I’m the Vice President of Corporate Communications and Investor Relations at CureVac.
Please let me introduce today’s speakers. On the call with me from CureVac are Alexander Zehnder, Chief Executive Officer of CureVac; Myriam Mendila, our Chief Scientific Officer; and our Chief Financial Officer, Axel Malkomes. Rudiger Wolff, Senior Vice President of Finance will be available for the Q&A session. Please note that this call is being webcast live and will be archived on the Events & Presentations section under Investor Relations on our website.
Before we begin, a few forward-looking statements. The discussions and responses to your questions on this call reflect management’s view as of today, Tuesday, November 12, 2024. We will be making statements and providing responses to your questions that state our intentions, beliefs, expectations, or predictions of the future. These constitute forward-looking statements for the purpose
Read the full article here
